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ABSTRACT  Univalent  antibody  fragments  prepared  from  a  rabbit  antiserum  raised  against 
whole  human  platelets  completely  inhibited  adhesion of  platelets  to  immobilized  trimeric 
collagen in a defined, Mg2+-dependent, adhesion assay. An octylglucoside extract of whole 
platelets  completely neutralized this antibody, and all neutralizing activity bound to immobi- 
lized wheat germ agglutinin. Further fractionation on concanavalin A gave rise to subfractions 
that each neutralized only partially at saturation, when tested against antibody concentrations 
that inhibit 50% of platelet-collagen adhesion. When tested against higher antibody concen- 
trations that completely inhibited adhesion, each subfraction  had no detectable neutralizing 
effect, although the combined subfractions neutralized completely. This and other evidence 
suggests that more than one platelet entity participates  in platelet-collagen adhesion. Although 
distinct, they appear to play interdependent roles in a single adhesion process. 
Considerable evidence is accumulating that a restricted num- 
ber of surface molecules are involved in cell adhesion.  The 
most extensively studied cell adhesion molecule (CAM), l N- 
CAM (l), is a large glycoprotein originally purified from chick 
neural retinal cells. It apparently mediates adhesion by direct 
association  of N-CAM  molecules  on  adjacent  cells  (1).  A 
glycoprotein  has  also  been  implicated  in  adhesion  in  the 
cellular slime mold Dictyostelium discoideum, but its role in 
the adhesion process is unclear (2, 3). 
The approach used to identify these CAMs has been largely 
immunological. Rabbits were immunized with a crude mem- 
brane fraction, and univalent fragments of the immunoglob- 
ulins that were raised were used to inhibit cell-cell adhesion 
in an in vitro assay. In both D. discoideum and chick neural 
retina, the antibody preparation blocked adhesion completely; 
and,  as  might  be  expected,  crude  extracts  of the  antigenic 
mixture used for immunization neutralized the antibodies. In 
both cases, a single glycoprotein was isolated that could com- 
pletely neutralize the antibody effects. This raised the possi- 
bility that  in  each  system  there  might  be  only  one  crucial 
Abbreviations used in this paper." C~, extract fraction that specifically 
bound to a concanavalin A column; Cn, extract fraction that flowed 
through a concanavalin A column; CAM,  cell adhesion  molecule; 
W~, extract fraction  that specifically bound to a wheat germ lectin 
column; Wa, extract fraction that flowed through a wheat germ lectin 
column. 
CAM, although others might still exist that were not immu- 
nogenic in the injected animals. 
Another experimental system under intensive investigation 
is the adhesion of human platelets to collagen (4, 5), which is 
an early step in hemostasis. This system is especially attractive 
in that platelets are specialized for adhesion. Platelet-collagen 
adhesion  is also of great clinical  significance  in  thrombotic 
and  bleeding  disorders.  Early  methods  of quantifying  this 
adhesion  by observing the association  of platelets with sub- 
endothelial collagen in blood vessels (6, 7) have been gradually 
supplemented by more defined assays (5, 8-11). Immunolog- 
ical techniques have been used in several attempts to identify 
molecules involved  in  platelet-platelet  aggregation  (12,  13) 
and adhesion (14,  15), but results in various adhesion systems 
have differed, in part because the assays used did not measure 
a well-characterized adhesion reaction. 
Recently, we described a quantitative assay of platelet adhe- 
sion to purified type 1 trimeric collagen covalently linked to 
plastic coverslips (10)  under well-defined experimental  con- 
ditions.  Adhesion  in  this  assay  required  a  native  collagen 
structure and was absolutely dependent on Mg  2*. This assay 
provided an opportunity  for identification  of the molecular 
basis of this  adhesion.  We show here that,  as expected,  an 
antiserum raised against human platelets completely inhibited 
platelet-collagen adhesion in our assay, and that these effects 
were  neutralized  by  platelet  extracts.  However,  in  contrast 
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saturating concentrations of subfractions of the platelet extract 
could not completely inhibit platelet-collagen  adhesion, rais- 
ing the  possibility  that  more  than  one entity  is directly  in- 
volved in adhesion in this system. In this article, we describe 
the results with a rabbit antiserum that led to this conclusion. 
In the subsequent  article  (16),  we describe  work that uses a 
monoclonal  antibody  and  has identified  one of the  partici- 
pating molecules. 
MATERIALS  AND  METHODS 
Platelet Adhesion Assay 
The adhesion of  gel-filtered human platelcts to trimeric collagen immobilized 
on plastic coverslips was assayed as described previously (10). Briefly, ~Cr- 
labeled  platelets  were prepared  and  separated  from plasma proteins  by gel 
filtration (17) in modified Tyrode's buffer, pH 7.4, containing  1 mg/ml glucose 
and 2 mg/ml bovine  serum albumin.  Type I collagen trimers,  derived from 
lathyritic chick skin (18), were covalently coupled to plastic coverslips using a 
carbodiimide  reagent. The coverslips were placed in Linbro wells (Flow Labo- 
ratories,  Inc.,  McLean,  VA)  and  covered  with  0.3  ml  of Tyrode's  buffer 
containing labeled platelets. The wells were incubated for l0 rain at 37°C on a 
gyratory shaker and washed. Adhesion, determined as 5tCr bound to coverslips, 
reached saturation within 20 rain, was Mg  2÷ dependent, and specific for collagen 
trimers or fibrils (10). 
Preparation of Adhesion-blocking Antiserum 
Rabbit antiserum  was raised by immunization with whole human platelets 
that were prepared  by gel filtration  as described  previously (10), except that 
bovine  serum albumin was omitted.  Platelets prepared  by this method con- 
tained <0.1% plasma proteins (flbrinogen or fibronectin) by radioimmunoassay 
and < 1% lymphocyte contamination.  The rabbit was injected with 109 platelets 
in complete  Freund's adjuvant  and was initially boosted at~er 28 d with  l08 
platelets  in  incomplete  Freund's adjuvant.  Repeated  boosts were  made at 
bimonthly intervals.  Sera were collected  5,  7,  and  9  d  after  the  third  and 
subsequent boosts and pooled, and IgG was prepared by affinity chromatogra- 
phy on a column of protein A-agarose (Pharmacia Fine Chemicals, Piscataway, 
NJ). The column was equilibrated in 75 mM Na-K phosphate, 0.15 M NaC1, 
pH 7.2. IgG was eluted with  l  M acetic acid, neutralized with solid Tris, and 
dialyzed into l0 mM Na phosphate, pH 7.3, 0.15 M NaC1, l mM EDTA, and 
5 mM ~-mereaptoethanol. 
To prepare  Fab,  mercuripapain  (Sigma Chemical  Co., St.  Louis, MO) in 
70% ethanol was added to the lgG preparation  at 20 ~1 per l0 ml oflgG (10 
mg/ml) and  digestion  was  carried  out  at  37°C for  l  h  (19). Papain  was 
inactivated by addition  of iodoacetamide  to 30 mM for 15 min at 37°C. After 
dialysis, Fab fragments were separated from Fc fragments by applying the digest 
to a second column of  protein A-agarose. The flow-through fraction, containing 
Fab, was collected. Purity was checked by gel electrophoresis in SDS. 
1251-Fab Binding to Intact Platelets 
Fab was labeled with  ~2~I, and its binding to platelets was determined  at a 
series of concentrations  essentially as described by Pidard  ct al.  (20) except 
platelets were prepared by gel filtration as in the adhesion assay. 
Antisera against Fibronectin, Fibrinogen, and 
Factor VIII/von Willebrand Factor 
High-titer rabbit antisera against human fibronectin and human fibrinogen 
were obtained  from Calbiochem-Behring  Corp.  (La Jolla,  CA). The antisera 
gave  strong  reactions  on  immunodiffusion  with  purified  antigens.  Rabbit 
antiserum against  Factor  VIII/von Willebrand  factor was the gift of Dr.  C. 
Hougie, University of California, San Diego. Fab fragments of IgG from these 
antisera were prepared as described above. 
Preparation of Outdated Platelet Extracts 
Outdated  human platelet packs were obtained  from the Veterans Adminis- 
tration  Hospital  Blood Bank, La Jolla, and the San Diego Blood Bank. Red 
blood cell contamination was reduced by repeatedly centrifuging at 500 g for 2 
min in a Sorvall GS-4 rotor (DuPont Instruments, Sorvall Biomedical Div., 
Newtown, CT) equilibrated  at  10°C, and discarding the pellet. Platelets were 
pelleted by centrifugation at 3,000 g for 15 min, resuspended in Tris saline (15 
mM Tfis-HCI, pH 7.4, 126 mM NaCI, 5.4 mM KCI, 5 x  10  -5 M CaCI2, I mM 
MgCI2, 0.1% glucose) and washed three to four times, until the supernatant  did 
not contain  appreciable  protein,  as measured  colorimetrically  (21). Platelets 
were then extracted by one of the following methods: 
FREEZE-THAW  EXTRACTION  OF  INTACT  PLATELETS:  Platelets 
were resuspended  in Tris  saline without EDTA, and the platelct suspension 
was frozen and thawed three times (22). Solubilized material was collected by 
centrifugation at  100,000 g for 1 h at 4°C. The supernatant  was collected and 
used in subsequent fractionations. 
OCTYLGLUCOSIDE  EXTRACTION  OF  INTACT  PLATELETS~ 
Platelets were resuspended in Tris saline containing  1% octylglucoside and 2 
#g/ml phenylmcthylsulfonyl  fluoride,  and were incubated  for  1 h  at  room 
temperature  on a shaker. Centrifugation  was performed  as above. To test for 
neutralizing activity of the supernatant  in the adhesion  assay, octylglucoside 
was removed by exhaustive dialysis against Tris saline, pH 7.4. The dialyzate 
was then clarified by centrifugation at 10,000 g in a Sorvall centrifuge. 
CHYMOTRYPSIN  TREATMENT  OF  INTACT  PLATELETS:  The 
platelet suspension was incubated with 0.4 U/ml insolubilized a-chymotrypsin 
(Sigma Chemical Co.) for 2 h at room temperature  on a shaker. Platelcts and 
enzyme-derivatized beads were removed  by cent~ifugation at 750 g. Phenyl- 
methylsulfonyl fluoride was added to neutralize any residual protease activity, 
and the extract was clarified at 100,000 g as described above. 
Assay of Antibody Effects on Adhesion and 
Their Neutralization 
Antibody effects on platelct-collagen  adhesion were determined  by prein- 
cubating the platelets in assay medium containing a series of concentrations  of 
immune Fab for l0 min at 37°C and then performing the adhesion assay over 
a  10-min period.  To test platelet extracts  for neutralization  of the  effects of 
immune Fab on platelet-collagen  adhesion,  a  series of concentrations  were 
reacted with  antibody  that was at  a  concentration  that  inhibited  -50%  of 
platelet-collagen  adhesion.  In  general,  antiplatelet  Fab,  at  15  ug/ml,  was 
preincubated  with serial dilutions of platelet extract for 30 min at 37°C. 5~Cr- 
labeled human platelets were then added and the tubes incubated  for l0 min 
in a 37°C water bath. Aliquots of 0.3 ml were added to triplicate Linbro wells 
containing  collagen-derivatized coverslips. Platelet adhesion was assayed over 
a  10-min period as described and quantified  by measuring 5~Cr bound to the 
coverslip.  Neutralization  of adhesion-blocking  antibodies  was calculated  as 
described by Brackenbury et al. (23) for each dilution of an extract: % neutral- 
ization =  % adhesion (Fab + extract) -  % adhesion (Fab alone)/%  adhesion 
(extract  alone)  -  % adhesion  (Fab  alone)  x  100. One unit of neutralizing 
activity  was  defined  as that  amount  that  gave  50%  neutralization  of the 
adhesion-blocking  antibody  under defined  conditions.  It  was estimated  by 
plotting the log of extract protein  concentration  against the percent  neutrali- 
zation for serial assay points and fitting a line by the least-squares method (24). 
Specific activity was obtained by dividing activity, in units per milliliter, by the 
extract protein concentration  (21), in milligrams per milliliter. 
Estimation of Platelet Lysis 
Because apparent inhibition  of adhesion  could  result  from platelet  lysis 
during the assay, with release of 5JCr, we evaluated lysis at the end of the assay 
incubation.  The supernatant  containing  unbound platelets and any free 5~Cr 
was collected and  lightly fixed with 0.5% paraformaldehyde  in  0.03 M  Na 
phosphate buffer, pH 7.4 (17) for l0 min. An aliquot was then filtered over a 
0.2-#m filter (Millipore Corp., Medford, MA), and free ~Cr in the filtrate was 
determined.  This was compared  to total 5~Cr in an unfiltered aliquot.  Under 
standard assay conditions, lysis estimated by this method was 0.3% or less, and 
was not affected by addition of immune Fab. 
Fractionation of Platelet Extracts on 
Lectin Columns 
The platelet extract was applied to a 3-ml column of  wheat germ agglutinin- 
agarose (Vector Labs, Burlingame, CA), equilibrated  in 0.05 M Tris-HCl, pH 
7.4, containing 0.15 M NaCl. After washing in this buffer, specific elution was 
carried  out with 0.1  M N-acetyl-o-glucosamine  in  this  buffer.  The fraction 
eluted from the wheat germ column W~, was dialyzed into 0.05 M Tris-HCl, 
pH 8, containing 0.15 M NaCl, 1 mM CaCl2, I mM MgCl2, and was chromat- 
ographed on a 2-ml column ofconcanavalin A-agarose (E-Y Laboratories, San 
Mateo, CA). The flow-through (W~Cn) was saved, and this column was eluted 
with 0. l M a-methyl  mannoside in the same buffer to give rise to the fraction 
W~C~. All fractions were dialyzed, lyophilized, and resuspended in Tris saline 
to assay neutralizing activity. 
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Platelet Extract, and Partially  Purified 
Antiplatelet IgG 
To partially purify the components of antiplatelet IgG that bound to entities 
that influenced platelet-collagen  adhesion, we prepared a fraction enriched in 
platelet proteins that did not neutralize the adhesion-blocking activity of the 
antiserum  and used this to adsorb  irrelevant  antiplatelet  antibodies.  To this 
end, an aliquot  of an octylglucoside extract of whole platelets was repeatedly 
passed through columns of wheat germ agglutinin-agarose,  and the final flow- 
through fraction, Wa, was collected. An aliquot of Wa containing  ~20 mg of 
protein was coupled to cyanogen bromide-activated Sepharose (Pharmacia Fine 
Chemicals) at 4"C (25). The gel was postincubated with 1 M ethanolamine,  pH 
9,  to block  unreacted  residues. Antiplatelet  IgG was then reacted  with this 
column by circulating  l0 mg IgG in phosphate-buffered  saline, pH 7.2, over 
Wa  agarose  for 24  h  at  4"C  (26). The  flow-through  fraction,  enriched  in 
antibodies  that blocked platelet-collagen  adhesion,  was collected, coupled to 
cyanogen bromide-activated Sepharose, and used to purify the platelet antigens 
with which it reacted. To re~over the antibodies that bound to the Wa agarose 
column, it was washed (26) and specifically eluted with 0.2 M diethylamine, 
pHI 1.5. The IgG fractions that flowed through and bound to the Wft agarose 
were digested to Fab fragments, as above, to assess their  binding to platelets 
and their effect on platelet-collagen adhesion. 
PAGE 
Samples were solubilized by boiling for 10 rain in 0.2 M Tris-HCl, pH 6.8, 
containing 2% SDS, 5% ~-mereaptoethanol,  and 10% glycerol and electropho- 
resed in  7.5% polyacrylamide  slab gels in 0.1% SDS in 0.1  M Tris-glycine 
buffer, pH 8.2. 
Prestained  standards  of Mr 200,000,  92,000,  66,000, 43,000,  and 26,000 
(Bethesda Research Laboratories, Gaithersburg, MD) were run in parallel lanes. 
Proteins were localized by silver staining (27). In some experiments in which 
neutralizing activity was studied, unfixed gels were sliced into appropriate zones 
and protein eluted by overnight incubation in SDS-containing buffer, and freed 
of SDS by addition of acetone as described by Hager and Burgess (28). Bovine 
serum albumin (radioimmunoassay  grade, Sigma Chemical Co.), 0.1  mg/ml, 
was used as a carrier protein. The eluted protein in each fraction was resolubil- 
ized in 40 ul of  6 M guanidine hydrochloride, diluted  1:50 with Tris saline, and 
dialyzed  extensively against  Tris  saline. Serial dilutions  were tested  in the 
platelet-collagen adhesion assay for antibody neutralizing activity. 
RESULTS 
Fab prepared from antiplatelet antiserum completely blocked 
platelet-collagen adhesion in a dose-dependent manner (Fig. 
1  ). Preimmune Fab had no effect (Fig. 1). Fab directed against 
fibronectin, fibrinogen, or Factor VIII/von Willebrand's fac- 
tor, implicated in other platelet functions also had no detect- 
able effect on our assay, even at 10- to 20-fold higher concen- 
trations. 
To determine the nature of the materials with which the 
antibody  reacted,  we  extracted  the  platelet constituents  in 
three ways--by freezing and thawing, by treatment with the 
nonionic detergent octylglucoside, or by treating the surface 
of the platelets with a protease, a-chymotrypsin. Each of these 
extracts could  completely neutralize  the  adhesion-blocking 
Fab, at the appropriate concentration which, with the octyl- 
glucoside extract, was ~350 ~g/ml (Fig. 2). The octylglucoside 
extract seemed preferable to the others as the starting material 
for further purification inasmuch as the freeze-thaw extract 
had a lower specific activity, and the a-chymotrypsin extract 
had  a  lower  total  yield  (Table  I).  The  latter  also  seemed 
undesirable  because  the  antigen  it  contained  might  be  a 
proteolytic  fragment  rather  than  an  intact  molecule.  The 
freeze-thaw procedure may also activate proteases and give 
rise to cleaved platelet glycoproteins (29),  notably the mem- 
brane glycoprotein, glycoprotein lb. 
Fractionation was then attempted by affinity chromatog- 
raphy on wheat germ lectin-agarose. The neutralizing activity 
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FIGURE  1  Effect of normal (O; preimmune) and antiplatelet rabbit 
Fab (e) on platelet-collagen adhesion. Fab was preincubated with 
S~Cr-labeled  human platelets for 10 min at 37°C and the adhesion 
of the platelets to immobilized trimeric collagen was determined as 
described  in  Materials  and  Methods.  Each  point  represents the 
mean +  SE of triplicate determinations. 
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FIGURE  2  Neutralization of adhesion-blocking Fab by platelet ex- 
tract. Dilutions of a dialyzed octylglucoside extract of human plate- 
lets were preincubated with antiplatelet Fab as described in Mate- 
rials  and  Methods,  and  the  effects  of  the  mixture  on  platelet- 
collagen  adhesion  was  determined.  Results  are  mean  +  SE  of 
triplicate  determinations.  Parallel  samples  were  incubated  with 
preimmune Fab and octylglucoside extract, and showed that adhe- 
sion was not directly affected by the extract. 
in both the octylglucoside extract and the freeze-thaw extract 
bound virtually completely to this column and could be eluted 
with N-acetyl-D-glucosamine (Table II). With both extracts, 
the small amount of neutralizing activity that flowed through 
the column was completely bound when once more applied 
to the column. The specific activity of the material purified 
from the octylglucoside extract was ~30-fold greater than that 
of the initial extract and that from the freeze-thaw extract was 
-20-fold greater. 
We then sought to subfractionate the wheat germ bound 
neutralizing material (designated W~) derived from the oc- 
tylglucoside extract, by affinity chromatography on concana- 
valin  A-agarose.  Some  of the  neutralizing  activity  flowed 
through the concanavalin A column (designated W~Cn) and 
could not bind even with repeated passage. Another fraction TABLE  I 
Extraction  of Antibody-neutralizing Activity from Whole 
Platelets 
Protein  Specific 
Extraction method  extracted"  activity 
mg  Ulmg protein 
Freeze-thaw  I. 12  5.2 
Octylglucoside  0.49  9.6 
cz-Chymotrypsin  0.I I  28.8 
Outdated human  platelets  were extracted and  neutralizing activity was 
calculated, as described in Materials and Methods. 
* Yield per 100 ml of blood. Starting material consisted of outdated human 
platelet packs. 
TABLE  II 
Fractionation of Neutralizing Activity on Wheat Germ Lectin- 
Agarose 
Protein  Neutral- 
re-  izing  Specific 
Fraction  covered  activity  activity 
% of applied  %  of ap-  Ulmg protein  plied 
1% Octylglucoside extract 
Flow-through fraction  70  3  0.4 
Bound and eluted fraction  5  89  291 
Freeze-thaw extract 
Flow-through fraction  72  10  0.7 
Bound and eluted fraction  4.3  82  99.2 
Outdated human platelets were extracted as described, and fractionated on 
wheat germ lectin-agarose. Neutralizing activity was calculated as described 
in Materials and Methods. 
bound to concanavalin A (designated WmC~) and was eluted 
with  a-methylmannoside. To our surprise,  neither  fraction 
was capable of completely neutralizing the Fab, even at high 
concentrations (Fig.  3),  although  the  starting material that 
had been eluted from the wheat germ lectin column neutral- 
ized completely. This was not due to protein losses on the 
column, because subsequent elution at low pH or with SDS 
did not release neutralizing activity. We consistently found 
that W~Ca was more potent than W~C~.  Under standard 
conditions,  in  which  neutralization  was  assayed at  a  Fab 
concentration that blocked 50% ofplatelet-coUagen adhesion, 
the former fraction neutralized up to -58% of the Fab and 
the latter up to -25% (Fig. 3). This was the maximum percent 
neutralization achieved with each fraction, and the addition 
of larger amounts of the fraction produced no further neu- 
tralization (Fig.  3). 
Because each of these fractions only neutralized partially 
under standard conditions (Fab at a concentration that inhib- 
its 50%  of the platelet-collagen adhesion), we analyzed the 
relative potency of the two subfractions and that of W~ over 
a wide range of Fab concentration. In each experiment, a Fab 
concentration  was  chosen  that  inhibited  platelet-collagen 
adhesion between 40-100%  based on dose-response curves 
prepared previously, and  a  series of concentrations of the 
fraction of interest were tested for neutralizing activity. Max- 
imal neutralization  was determined as in Fig.  3.  We found 
that W~ could, at an appropriate concentration, completely 
neutralize the Fab, irrespective of the degree of inhibition of 
adhesion by Fab (Fig.  4).  In contrast, the two subfractions, 
each of which partially neutralized at Fab concentrations that 
inhibited  platelet-collagen adhesion in the  50%  range,  had 
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FIGURE  3  Asymptotic neutralization of adhesion-blocking Fab by 
subfractions of a  platelet extract. The Wbd fraction of the platelet 
octylglucoside extract was subfractionated  on a  concanavalin A- 
agarose column and the neutralizing effects of a series of concen- 
trations of the two subfractions, WbdC~ (@) and WudCbd (O),  were 
determined. Results are.the mean +  SE of these determinations. 
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PERCENT INHIBITION OF AOHESION  BY Fab 
Maximum neutralizing  activity of fractions  of a platelet 
extract as a function of inhibition of platelet-collagen adhesion by 
a series of dilutions of antiplatelet Fab. The fractions Wud, WbdCbd, 
and Wt~l::~ were prepared from an octylglucoside extract of human 
platelets by lectin-affinity chromatography. A  recombined fraction 
containing equal amounts  of WbaC~  and  WbaCff was also tested. 
Maximum neutralization of Fab at each dose of Fab was determined 
as in Fig. 3. 
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trations that  inhibited  close  to  100%  (Fig.  4).  However, a 
mixture of the two fractions could, like the parent fraction, 
neutralize totally, even at Fab concentrations that inhibited 
platelet-collagen adhesion very extensively (Fig.  4). The im- 
plications of these findings will be considered later. 
Because WbdCn was the more potent subfraction, we further 
fractionated it by PAGE in  SDS.  The fractions were eluted 
from the gel and their neutralizing activity was determined 
under standard conditions in which Fab concentrations that 
inhibited 50%  of platelet-collagen adhesion were employed. 
Two active fractions were resolved by this  procedure.  One 
with Mr ~  90,000-100,000  produced  maximum neutraliza- 
tion of ~40% (Table III). Another with Mr ~  110,000-130,000 
produced maximal neutralization in the range of 20%.  This 
latter fraction was initially isolated from two slices of the gel 
(Table lll), but probably represents a single material that runs 
in both fractions, inasmuch as combining the contents of the 
two fractions gave no greater maximum neutralization than 
was observed with each alone. This electrophoretic procedure 
apparently resolves two antigenically distinct entities in the 
W~CE, fraction,  so that together with WbdC~, three distinct 
neutralizing fractions apparently exist. Their relationship will 
be considered later. 
Electrophoretic  analysis  of W~,  W~CB,  and  WbdC~  by 
PAGE  in  SDS  under  reducing  conditions  revealed  many 
protein  bands that  reacted  with a  silver stain  (not  shown). 
Because all these fractions were so impure, we turned to an 
alternative purification approach, by taking advantage of the 
fact that the portion of the octylglucoside extract that failed 
to bind to a wheat germ lectin column (Wa) had no detectable 
neutralizing activity. We,  therefore, coupled WE, to  agarose 
and exhaustively adsorbed an IgG fraction prepared from our 
crude  antiserum  on  this  column.  Unbound  IgG  retained 
adhesion-blocking activity, but many other antiplatelet anti- 
bodies were removed by the column. We then used the IgG 
preparation  enriched  in  neutralizing  activity as  an  affinity 
adsorbant by covalently linking it to agarose. Extract constit- 
uents that had neutralizing activity should bind to this col- 
umn, although  many other platelet constituents  might well 
also bind. 
The fraction  of Wbd that bound to this column and  was 
specifically eluted  at  pH  11.5 contained  only three  major 
protein bands upon PAGE (Fig.  5). It will be referred to as 
"enriched  neutralizing  antigen."  The  very prominent band 
with Mr ~  125,000  (Fig.  5,  arrow) migrated exactly with a 
purified preparation of platelet glycoprotein IIb and the prom- 
inent  band  below  it  with  Mr  ~  i00,000  co-migrated with 
platelet glycoprotein IIIa. The enriched neutralizing antigens 
neutralized antiplatelet Fab effects on platelet-collagen adhe- 
sion in a dose-dependent manner up to a maximum of ~50% 
inhibition (Fig. 6). 
Given the fact that none of the subfractions prepared from 
W~  neutralize  Fab  completely,  it  is  difficult  to  compare 
formally their relative potencies and  specific activities with 
each other or with the  starting fraction,  Who. The data  are 
summarized in Table IV. Here we show maximum neutrali- 
zation achieved with each subfraction under standard  assay 
conditions (Fab concentration that inhibits 50%  of platelet- 
collagen  adhesion),  and  the  protein  concentration  of each 
subfraction required to produce half the maximum neutrali- 
zation achievable with that fraction. Based on these compar- 
isons,  it  appears  that  the  enriched  neutralizing  fraction  is 
relatively potent, although it is clearly not capable of neutral- 
izing antibody completely. It is likely that it is enriched in at 
least one relevant molecule and, based on work with mono- 
clonal antibodies reported in the subsequent article (16),  the 
TABLE III 
Fractionation of Antibody-neutralizing Activity by PAGE in SDS 
Maximum neutrali- 
zation observed 
Eluted zone  Mean _+ SE 
Dye front-90  1 +  5 
90-100  40 +__ 17 
100-110  6 +  10 
110-120  19 +  3 
120-130  23 +  9 
130-140  0 +_ 5 
140-150  -10 _+ 14 
150-160  -15 _+ 8 
160-170  -15 +  16 
170-top of gel  -1  -4- 10 
Starting material: 
W~Cf,  58 _+ 8 
An octylglucoside extract of whole platelets  was reacted with a wheat germ 
lectin-agarose column and the bound material  that had been eluted with N- 
acetyl-glucosamine  was  passed  through a concanavalin A-agarose column. 
This  material  (W~Cf,)  was subjected to slab gel electrophoresis  and the gel 
was  cut  into zones and  eluted, all  as described  in  Materials and  Methods. 
The  zone  dye  front-90  includes  all  material  between  the  dye  front  and 
apparent Mr -90,000; the zone 90-100 includes all  material  with apparent 
M, ~90,000-100,000, etc.  The apparent M,s  are all  based  on  migration  of 
prestained standards  run in parallel  lanes of the slab gel. Maximum neutrali- 
zation was measured  as in Fig. 3. 
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FIGURE  5  PAGE of enriched neutralizing antigens. Electrophoresis 
was performed as described in Materials and Methods. The gel was 
stained with silver nitrate (27). Migration of molecular weight stand- 
ards  with  Mr  ~  200,000,  93,000,  68,000,  43,000,  and  26,000  is 
indicated.  The  dye front  was slightly  below the  standard with  Mr 
~26,000. The arrow indicates the migration of platelet glycoprotein 
lib, determined by electrophoresis of a preparation (the kind gift of 
Dr.  E.  Plow, Scripps Clinic and  Research Foundation, La Jolla, CA) 
enriched in this protein on a parallel lane of the slab gel. z  BO 
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FIGURE  6  Neutralization of antiplatelet Fab  by enriched  neutral- 
izing  antigens.  Enriched  neutralizing  antigens  were  prepared  as 
described in the text, dialyzed into  modified Tyrode's buffer,  pH 
7.4,  and tested  in  the adhesion assay against antiplatelet  Fab,  as 
described in Materials and Methods. Each data point was assayed 
in triplicate and is expressed as mean _+ SE. 
molecule with Mr -  125,000, which appears to be glycoprotein 
IIb (30),  probably contributes to the neutralizing activity of 
this fraction. 
We also used the antibody that bound to the Wa fraction 
in another way. Because it had no effect on platelet-collagen 
adhesion but bound many platelet antigens, we could use it 
to assess the amount of "nonspecific" Fab that can bind to a 
platelet without affecting its adhesion to collagen. |25I-labeled 
Fab prepared from this fraction bound extensively to platelets, 
saturating  at  -2  x  l06  Fab  molecules/platelet  (data  not 
shown).  Under these conditions,  platelet-collagen adhesion 
was normal.  In contrast,  binding a  comparable number of 
Fab molecules of an active preparation inhibited adhesion by 
at least 50%. 
DISCUSSION 
Univalent antibody fragments prepared from a  rabbit anti- 
serum  raised  against  whole  human  platelets  completely 
blocked platelet-collagen adhesion in a quantitative assay. In 
contrast, univalent antibody fragments directed against fibro- 
nectin, fibrinogen, and Factor VIII/von Willebrand's factor 
had no effect upon platelet-collagen adhesion in our assay, 
even at concentrations 50-100 times greater than the effective 
dose for antiplatelet antibody. Thus, although these glycopro- 
teins play important roles in platelet aggregation (12,  14, 31, 
32) and antifibronectin (15)  or anti-Factor VIII/von Wille- 
brand's  factor (8,  9,  32)  have  been  reported  to  influence 
platelet behavior in other assays, they do not appear to be 
required in our assay in which platelet aggregation is mini- 
mized. 
As in other cell adhesion systems, a crude extract of platelets 
completely neutralized the adhesion-blocking activity of our 
crude antiserum. In other adhesion systems (1,  2,  33-36),  a 
single antigenic substance was identified as a CAM, and could 
completely  neutralize  the  antiserum.  What  is  remarkable 
about the present experiments is that subfractions of  the crude 
extract contained activity that only partially neutralized the 
adhesion-blocking antibodies, even at saturating conditions. 
The partial neutralizing effects of these subfractions were 
highly dependent  on the  concentration  of Fab used in the 
adhesion  assay.  At  relatively  low  Fab  concentrations  that 
inhibited  ~50%  of platelet--collagen adhesion,  subfraction 
W~Cn neutralized up to 60% of  the adhesion-blocking activity 
of the Fab, and subfraction W~C~ neutralized up to ~25%. 
These levels of neutralization were maximal, in that adding 
increasing amounts of either neutralizing fraction to a  con- 
stant amount of Fab did not produce further neutralization. 
At high Fab concentrations that inhibited 80-90% ofplatelet- 
collagen adhesion, neither subfraction had a statistically sig- 
nificant effect on platelet-collagen adhesion, even if assayed 
at high concentrations. In striking contrast, a mixture of these 
two subfractions or the  parent  fraction,  W~,  could totally 
neutralize Fab at this concentration. 
These findings indicate that the W~Cn and Wb~C~ contain 
immunologically distinct entities, each capable of neutralizing 
a  different  subpopulation  of adhesion-blocking Fab.  Each 
subpopulation  of Fab  is  apparently capable  of completely 
inhibiting platelet-collagen adhesion inasmuch as complete 
neutralization of  one subpopulation at high Fab concentration 
has no effect on the ability of the other,  unneutralized Fab 
subpopulation to inhibit all platelet--collagen adhesion. 
The dependence of the neutralizing effect of the different 
subfractions on the Fab concentration suggests that all of the 
active molecules detected here function in a single, dependent 
pathway leading  to  platelet-collagen adhesion,  rather than 
mediating parallel, independent types of adhesion. If the two 
fractions did  represent  entities  that  mediated  independent 
types of adhesion,  each should neutralize the complex Fab 
mixture up to the  same saturation level irrespective of the 
Fab concentration used, provided enough is added to bind all 
the Fab that reacts with it.  Yet, the data indicate that even 
high concentrations of either W~Cn or W~C~ are completely 
unable to neutralize high concentrations of the complete Fab. 
This is consistent with the idea that molecules contained in- 
W~Cn and WbdC~ participate in a dependent adhesion path- 
way rather than in independent ones. If enough Fab is added 
to fully block either the relevant components of W~Cn or of 
W~C~ on the platelet, complete inhibition  of adhesion re- 
sults.  Neutralizing the Fab directed against one component 
does not  restore adhesion  as long as the  other component 
remains blocked. 
TABLE IV 
Comparisons of the Activity of Various Neutralizing  Fractions 
Fraction 
Protein re-  Protein re- 
quired for  quired for 
Maximum  half-maxi-  maximum 
neutraliza-  mum neu-  neutraliza- 
tion  tralization  tion 
~glml 
Octylglucoside extract  100  104  300 
Wbd  100  10  36 
WbdCft  58  13  65 
WbdCbd  24  10  48 
Enriched neutralizing  50  4  7 
antigen 
Summary of measures of the relative neutralizing activity of a platelet extract 
and fractions derived from it.  Maximum neutralization for each fraction (i.e., 
the  maximal  percent  neutralization  that  saturating concentrations of this 
fraction can produce, when assayed against Fab concentrations that inhibit 
50% of adhesion) was determined  as in  Fig. 3. This became the  basis for 
further comparisons. The concentration of protein required to produce half 
maximum neutralization and the minimal concentration that produced max- 
imum neutralization is tabulated. 
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obtained with a monoclonal antibody in the subsequent arti- 
cle (16). That antibody, although apparently directed against 
a  single  platelet  glycoprotein,  can  totally  inhibit  platelet- 
collagen adhesion. Yet the antigen to which it is directed only 
partially neutralizes the polyclonal Fab used here, to a maxi- 
mal  level  of  ~25%  (16).  This  again  suggests  that  several 
platelet entities participate in jplatelet-collagen adhesion, and 
that they are not independent. 
It remains possible that the multiple adhesion determinants 
discovered in this assay might represent protease fragments 
of a single adhesion molecule, each containing unique anti- 
genic sites. Octylglucoside extraction of platelets may result 
in the release of proteases which could, despite phenylmeth- 
ylsulfonyl  fluoride  treatment,  degrade  adhesion  molecules 
into smaller fragments. However, it would be necessary for 
the degradation to be complete, with no survival of the parent 
molecule, to lead to the results we found, which seems very 
unlikely. 
The  subfraction W~C~  can  be  further resolved into two 
subfractions by PAGE  in SDS.  Again, the two subfractions 
resolved by this procedure appear to be antigenically distinct 
because each is capable of neutralizing antibody only up to a 
maximum level that  is considerably lower than that of the 
parent fraction.  The  smaller of the two active  subfractions 
does  not appear to be  a  degradation  product of the larger 
active subfraction because, were this the case, the larger would 
be  expected  to  be  as effective a  neutralizer as  the starting 
material,  WbaCf,. It  is possible  that both  fractions are frag- 
ments of a single, even larger molecule which contains both 
groups  of antigenic  determinants.  However,  were  this  the 
case, one would have to conclude that the parent molecule 
was  either  completely  degraded  into  these  two  fragments 
during fractionation, or was so large that it did not enter the 
polyacrylamide gel,  because no active  neutralizing material 
was  found  with Mr  greater than  ~130,000.  It  seems more 
likely that  the two  subfractions resolved by  electrophoresis 
are distinct antigenic entities and possibly are distinct molec- 
ular entities, each playing a different but interdependent role 
in  platelet-collagen  adhesion,  following reasoning like that 
detailed  above.  Whether  the  antigenically  distinct  entities 
represent distinct posttranslational modifications of one mol- 
ecule or fundamentally different molecules that play different 
roles in platelet-collagen adhesion cannot be determined from 
this analysis. The fact that N-CAM exists in different forms, 
based on posttranslational modifications (1) provides a prec- 
edent for this possibility. 
Given the apparent complexity of the system, we sought a 
way to separate the relevant components by first  selectively 
purifying the crude antibody preparation and then using it to 
further  purify  the  subfractions  that  had  been  resolved  by 
lectin-affinity chromatography, This procedure gave  rise to 
an  active  enriched  neutralizing  fraction  that  contained  a 
relatively small number of protein bands, including a promi- 
nent protein with Mr -  125,000. This fraction could form the 
basis  for further rounds of immunization and purification, 
following the "iterative approach" (1). An alternative was to 
turn to monoclonal antibodies to help resolve this complex 
situation. In the following article (16), we describe the utility 
of monoclonal antibodies in  identifying one component of 
this adhesion mechanism. 
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